Current through Reg. 50, No. 187; September 24, 2024
The standards of practice in this rule do not supersede the
level of care, skill and treatment recognized in general law related to
healthcare licensure. All dentists who are authorized to prescribe controlled
substances shall comply with the following:
(1) Definitions.
(a) Acute Pain. For the purpose of this rule,
"acute pain" is defined as the normal, predicted, physiological, and
time-limited response to an adverse chemical, thermal, or mechanical stimulus
associated with surgery, trauma, or acute illness. The term does not include
pain related to:
1. Cancer.
2. A terminal condition. For purposes of this
subparagraph, the term "terminal condition" means a progressive disease or
medical or surgical condition that causes significant functional impairment, is
not considered to be reversible without the administration of life-sustaining
procedures, and will result in death within 1 year after diagnosis if the
condition runs its normal course.
3. Palliative care to provide relief of
symptoms related to an incurable, progressive illness or injury.
4. A traumatic injury with an Injury Severity
Score of 9 or greater.
(b) Prescription Drug Monitoring Program
(PDMP) or "the system." For the purpose of this rule, the system is defined as
the Florida Department of Health's electronic system to collect and store
controlled substance dispensing information as set forth in section
893.055, F.S.
(c) Substance Abuse. For the purpose of this
rule, "substance abuse" is defined as the use of any substances for
non-therapeutic purposes or use of medication for purposes other than those for
which it is prescribed.
(2) Standards. The nature and extent of the
requirements set forth below will vary depending on the practice setting and
circumstances presented to the dentist. The Board has adopted the following
standards for the prescribing of controlled substances for acute pain:
(a))Evaluation of the Patient. A medical
history and physical examination appropriate for the patient's clinical
condition must be conducted and documented in the medical record. The medical
record also shall document the presence of one or more recognized medical
indications for the use of a controlled substance.
(b) Treatment Plan. The written treatment
plan shall indicate if any further diagnostic evaluations or other treatments
are planned including non-opioid medications and therapies if indicated. After
treatment begins, the dentist shall adjust medication therapy, if necessary, to
the individual medical needs of each patient.
(c) Informed Consent and Agreement for
Treatment. The dentist shall discuss the risks and benefits of the use of
controlled substances including the risk of abuse and addiction as well as
physical dependence with the patient, persons designated by the patient, or
with the patient's surrogate or guardian if the patient is incompetent. The
discussion shall also include expected pain intensity, duration, options, use
of pain medications, non-medication therapies, and common side effects. Special
attention must be given to those pain patients who are at risk of misuse or
diversion of their medications.
(d)
Periodic Review. Based on the circumstances presented, the dentist shall review
the course of treatment and any new information about the etiology of the pain.
Continuation or modification of therapy shall depend on the dentist's
evaluation of the patient's progress. If treatment goals are not achieved,
despite medication adjustments, the dentist shall reevaluate the patient and
determine the appropriateness of continued treatment. The dentist shall monitor
patient compliance of medication usage and related treatment plans.
(e) Consultation. The dentist shall refer the
patient as necessary for additional evaluation and treatment in order to
achieve treatment objectives. The management of pain in patients with a history
of substance abuse or with a comorbid psychiatric disorder requires extra care,
monitoring, and documentation, and may require consultation with or referral to
an expert in the management of such patients.
(f) Medical Records. The dentist is required
to keep accurate and complete records to include, but not be limited to:
1. The medical history and a physical
examination, including history of drug abuse or dependence, if indicated,
2. Diagnostic, therapeutic, and
laboratory results,
3. Evaluations
and consultations,
4. Treatment
objectives,
5. Discussion of risks
and benefits,
6.
Treatments,
7. Medications
(including date, type, dosage, and quantity prescribed),
8. Instructions and agreements,
9. Drug testing results if
indicated,
10. Justification for
deviation from the 3-day prescription supply limit for a Schedule II opioid
controlled substance for acute pain,
11. Outline of problems encountered when
attempting to consult the PDMP, if the system was non-operational or the
clinician, or his or her designee, is unable to access the PDMP due to a
temporary technological or electrical failure; and
12. Periodic reviews. Records must remain
current, maintained in an accessible manner, readily available for review, and
must be in full compliance with rule
64B5-17.002, F.A.C., sections
456.057,
466.018, and
466.028(1)(m),
F.S.
(g) Compliance with
Laws and Rules. Dentists shall at all times, remain in compliance with this
rule and all state and federal laws and regulations addressing the prescribing
and administration of controlled substances.
Rulemaking Authority
456.44(4),
466.004 FS. Law Implemented
456.44(4)
FS.
New 8-12-02, Amended
12-4-18.